May 23, 2012 (Atlanta, Georgia) - Last week, the draft policy, prostate cancer screening in 2011 the U.S. Preventive Services Task Force (USPSTF), led to a significant burden of disease and treatment costs. According to the new revised proposal to competitors.Director of the University of Colorado Denver Health Sciences Center, University of urologic oncology section, Dr. E. David Crawford and his colleagues at the American Urological Association 2012 Annual Scientific Meeting of the proposal here presented an analysis of breaking oral session.USPSTF prostate cancer screening (not recommended, harm than good, or no net gain) D class this week. Proposal, however, to prevent prostate cancer screening, Dr. Crawford and his colleagues analyzed the treatment of advanced disease may end up spending more, there was a lot of cases.Prostate cancer, T0 lung cancer, colorectal cancer and Ovarian (PLCO) cancer screening (N = 33 709) 2011 trial, participants formed the basis for its conclusions. Sufficient for at least 55 issues of prostate-specific antigen (PSA) levels, age and mailing was a positive digital rectal examination. 7. Or a Gleason's definition of clinically significant cancers.Prostate cancer-related health expenditures, on the basis of the estimated cost of the publication in 2010. Results of regional events in the cancer population (N = 202 500), control, Epidemiology, and End Results (SEER) is expected to be.Prostate cancer, screening a total of 2580 men T0 PLCO trial treatment. Total expenditure per patient was $ 61.5 million ($ 23,804), respectively. T0 a total of 377 patients with clinically significant prostate cancer, spending $ 8.6 million ($ 22,742 per patient) is estimated. Back at the national level estimated $ 2400000000 96 000 cases of clinically significant prostate cancer (SEER data), the annual diagnosis / treatment cost extrapolated.Saving, spending, but then the StartUSPSTF recommendations Crawford, Ph.D., and the first deposit of $ 240 million U.S. dollars suggestions colleagues may lead to smoking cessation, but I most of these people, then clinically significant prostate cancer and overall health care costs than 2.4 billion U.S. dollars, Dr. Crawford said."" No-screening policy at the community level is a bad investment.This will reduce the cost of treatment for prostate cancer, 0.57% from 1.22% to miss important cases, prostate cancer, screening interval increases, "he explained.He said: "the right man far more cases of prostate cancer [metastatic] lead to significant impacts and risks, it is a more reasonable policy to be clinically significant prostate cancer detection and early treatment is recommended that screening of the disease shows significant prostate cancer will be missed.Wake-up CallWake up, "I called on USPSTF recommendations, I think," ", this is not business as usual and screening," Dr. Crawford after his presentation tells WebMD Medical News. "This, this is ignored, a warning sign, but a lot of comments [USPSTF paper is too true," he said.Dr. Crawford suggested to read the entire report in urology, and be open-minded. "We have a separate diagnosis and treatment of such a scan range and a better indicator of progress, some recommendations, such as expansion, to handle and should make joint efforts to implement," he said.Dr. Crawford, the main effect of the new proposal to find a reason to stop prostate cancer screening, family medicine doctor why he said that? (That is, litigation) legal remedies for the diagnosis of prostate cancer, PSA levels and fail to understand chaos, "he said.Does not always lead to diagnosis to treatmentSession moderator of Chicago, Anthony Shaffer, MD, Urology, Northwestern Memorial Hospital in Illinois, tells WebMD Medical News, the "problem" has developed. He is one of the most important concepts in the therapy does not cause the diagnosis is always said, this is what we need to understand people."Any person test option on all the variables that affect them, and I want to make sure that the next step, but the trail start automatically, may be destined to go all the way to the final concept of play is simply not how the real world," he said.Boshixiefu the patient should be given according to the patient's PSA test. "It's a free world - some people than others, there is work to ensure that information is not steady, there is risk adverse."This debate continues.Fund the study was not a commercial. Dr. Crawford and description of any financial relationships Boshixiefu.
Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such
Prostate screenings are no longer advisable unless the doctor really recommends it. But the annual screenings are not really required. Just take care of prostate health - eat healthy, lose a few pounds, take a prostate supplement and exercise regularly. Read a few reviews of Super Beta Prostate to understand how specific nutrients can help protect prostate health over the years.
ReplyDelete